NEWS USA TODAY z MONDAY, OCTOBER 21, 2019 z 5A
cided voters continues to grow as Dem-
ocratic caucusgoers pause to reevaluate
the changing field.”
The number of caucusgoers who say
they are undecided has spiked 8 points
since Juneto 29%. Among those who
have a preferred candidate, nearly two-
thirds (63%) say they might change
their minds before the caucuses.
Among the second tier of candidates,
activist Tom Steyer was at 3%. Three
other candidates also reached 3% be-
cause of rounding: Hawaii Rep. Tulsi
Gabbard, Harris and Klobuchar.
The Iowa caucuses, now 105 days
away, historically have had an outsize
influence in propelling the winner into
the primaries that follow in New Hamp-
shire and South Carolina – and in cre-
ating sobering challenges for those who
do worse than expected.
At 37, Buttigieg is the youngest con-
tender in the field, and he is the first
openly gay candidate to seek the Demo-
cratic Party’s presidential nomination.
He has gained ground through strong
performances in the Democratic de-
bates: Among those surveyed who
watched the debate last Tuesday, 4 in 10
said Buttigieg was the candidate who
did better than they expected.
An additional 3 in 10 cited Minnesota
Sen. Amy Klobuchar as doing better
than expected, although so far that
hasn’t translated into support. She is
just below 3% in the poll.
Biden was by far the candidate seen
as doing worse than expected in the de-
bate, cited by 1 in 4 poll respondents.
Among debate-watchers only, Butti-
gieg held a narrow lead in the poll, at
19%. Biden and Warren were tied at 17%.
There were other signs of a friendly
political landscape for Buttigieg and
Warren in the poll. They led the field as
the second choice of respondents; War-
ren was picked by 22% and Buttigieg by
14%. That could be important if and
when other candidates drop out of therace, or if other candidates fail to reach
the 15% threshold for delegates in the
caucuses and caucusgoers decide to
move to another contender.
In the survey, Democrats who
hadn’t named Warren as their first or
second choice were asked why they
weren’t supporting her. In the open-
ended question, the three most fre-
quent responses were: that they didn’t
know enough about her; that they
might support her; and that they were
undecided. Those are all factors that
the Massachusetts senator could ad-
dress in her campaign.
Others said they didn’t agree with
her on issues. About 5% said she
wasn’t electable or couldn’t defeat
President Donald Trump.
When the same question was asked
in the June survey about why Demo-
crats hadn’t named Biden as their first
or second choice, the most frequent
response was that he was too old. Oth-
ers said they wanted fresh ideas.
The telephone poll has a margin of
error of plus or minus 4.4 points.Democratic presidential candidate former Vice President Joe Biden, left, Sen. Elizabeth Warren, D-Mass., and South Bend
Mayor Pete Buttigieg, right, participate Tuesday in a Democratic presidential primary debate hosted by CNN/New York
Times at Otterbein University in Westerville, Ohio. JOHN MINCHILLO/AP
Poll
Continued from Page 1A
Researchers find second warship
from WWII Battle of MidwayA group of deep-sea researchers
looking for sunken World War II ships
found a second Japanese aircraft car-
rier that went down in the Pacific dur-
ing the historic Battle of Midway.
Rob Kraft of Vulcan Inc. said a re-
view of data captured Sunday shows
what could be either the Japanese car-
rier Akagi or the Soryu.Schumer calls for federal probe
of contaminated baby foodThe Senate’s top Democrat is call-
ing on the Food and Drug Administra-
tion to examine a report that found
dozens of baby food products contam-
inated with lead and other metals.
Sen. Chuck Schumer said Sunday
the FDA must take more action to reg-
ulate the baby food industry. A study
by Healthy Babies Bright Futures
found the presence of heavy metals in
95% of the 168 baby foods tested.Italian experts defuse WWII
bomb in northern cityItalian authorities evacuated 4,
people from the center of the northern
city of Bolzano on Sunday to defuse a
World War II bomb found during con-
struction. Three experts defused the
500-pound American bomb during a
three-hour operation that also forced
60,000 people to stay in their homes
and closed sporting complexes and
churches, ANSA reported.Pelosi in Jordan for ‘vital
discussions’ amid Syria crisisHouse Speaker Nancy Pelosi led a
group of American lawmakers on a
surprise visit to Jordan to discuss “the
deepening crisis” in Syria amid a
shaky U.S.-brokered cease-fire.
The visit came after bipartisan
criticism in Washington has slammed
President Donald Trump for his deci-
sion to withdraw the bulk of U.S.
troops from northern Syria, clearing
the way for Turkey’s offensive against
the Kurdish groups.
Turkey agreed on Thursday to sus-
pend its offensive for five days.
From staff and wire reportsIN BRIEFADVERTISEMENT
Good News for Americans, Bad News for Pain Drugs
Millions areexpected to benefit from a new technology that couldrelieve ye ars of severe joint discomfort;
reprograms the body to block slow burning inflammation instead of creating it
THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION. THIS PRODUCT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE OR PREVENT ANY DISEASE. RESULTS MAYVARY.
Veraflex producers are making these new pills as fast as possible
to meet the growing and increasing demand.Severa l of the major drug
companies behind popular pain
relievers may take a financial hit as
manufacturing of a new pill is now
complete.
Using a new technology, the
pill could be safer and more
effective than many store bought
brands.
The pill,VeraFlex,was de vel-
oped in May of thisyear by a
private company in Seattle.
Functioning primarily as an im-
mune modulator, the pill targets
the body’s immunesystem which
can decrease pain in the body.
The Science BehindRelief
Research shows that the joint
stiffness, soreness and discom-
fort associated with arthritis is
causedby inflammation which
attacks healthy cartilage and
protective tissue.
And according to leading med-
ical scientists, this inflammation
is causedby two inflammatory
enzymesreleasedby the body’s
immunesystem.
Remarkably, the active ingre-
dients inVeraFlexhelp to block
the production of both these
enzymes,resulting in a dramatic
decreasing in swelling, inflam-
mation, and discomfort.
Right now, the leadingover-
the-counter pills are only able to
block one of these enzymes!
It’s why so many sufferers fail
to ever findrelief.
Years of Discomfort
Relieved in 5 Days
“VeraFlexusers can generally
expect more flexibility in three
days...their joint pain alleviated
in five days...and in just seven
days, a tremendous improve-
ment in overall joint function
that may help them move like
they didyears prior”explains Dr.
Liza Leal, developer and spokes-
person forVeraFlex.8 patents that spread from the
US into Canada. And aswould
one guess, it’s backed by an
enormous amount of research,
including two patient clinical
trials.
In the first, 60 participants with
rheumatoid arthritis and/or os-
teoarthritiswere randomly placed
into four groups.
Two groupsweregiven the pat-
ented ingredient inVeraFlex, one
was given the drug Celecoxib,
and the last group a placebo. The
resultsweremonitored at30, 60,
and 90 days.
The data collectedby re search-
ers was stunning.
The groups taking theVeraFlex
ingredient saw staggering
improvements in arthritissymp-
toms such as flexibility, discom-
fort and function.
And even more astonishing
they experienced a dramatic
reduction in painby the 30-day
mark thatwas even better than
Celecoxib, a powerful drug!
A second studywas conducted
to ensure the datawas accurate
and again theresults participantsexperienced taking the VeraFlex
compound blewaway researchers.
This time it beat out the drug
Naproxen. Shockingly, both
men andwomenexperienced a
reduction in joint stiffness two
days faster than when using
Naproxen.
“I have to admit I was sur-
prised when I read the initial
findings” explains Leal. “But
whenyou look at the science it
just makes sense. It’s going to
changeeverything.”
Faster Delivery, Maximum
Absorption
VeraFlexis mainly comprised
of two patented ingredients:
Univestin, a powerful immune
modulator which blocks the
enzymes which causeyour joints
to hurt and BiAloe, an absorp-
tion enhancer (accelerator) that
ensures maximum potency.
Research shows that severe
joint discomfort arises when the
immune system goes haywire
andreleases COX and LOX into
your blood stream, two enzymes
that causes tremendous swell-
ing and inflammation aroundcartilage and protective tissue.
Over time, this inflammation
overwhelms the joint and it
begins to deteriorateresulting in
a daily battle with chronic pain.
Unfortunately, modern day
pain pills are only able block
only one of these enzymes,
resulting in marginalrelief and
continued suffering.
The Univestin in VeraFlex
is one of the only known sub-
stances which has been proven
successful in blocking both en-
zymes,resulting in phenomenal
relief from thewors t kinds of
discomfort.
The addition of BiAloe, a
unique aloevera extra, maximiz-
es the delivery of the plant based
Univestinextract toevery joint in
the body because it is proven to
improve nutrient absorption for
maximumresults.
AloeVera also is proven to
support the body’s immune
system which manages inflam-
mation, further supportingrelief.
How to Claim aFree
3-Month Supply OfVeraFlex
This is the official nationwide
release ofVeraFlex. And so, the
company is offering ourreaders
up to 3 FREE bottles with their
order.
This special give-away is avail-
able for the next 48-hours only.
All you ha ve to do is call toll free
1-800-234-7806and provide the
operator with the Free Bottle
Approval Code: VF350. The
company will do therest.
Important: Due toVeraFlex’s
recent mediaexposure, and Dr.
Leal’s latest book deal, phone
lines are often busy. If you call
and do not immediately get
through, please be patient and
call back. Those who miss the
48-hour deadline may lose out
on this free bottle offer.“It’s an incredibly powerful lit-
tle pill. And with the addition of
a patented absorption enhancer,
it packs aneven greater punch.
That’s why I’m soexcited to be
the first to share theseresults.
It’s giving sufferers their life
back.”
A Safer, More Effective
Avenue to AmazingRelief
Its widely accepted through
the medical community that
inflammatory enzymes are the
primary cause of pain and suffer-
ing in millions of Americans. It’s
why most prescriptions andeven
nonprescription pills are designed
to block them.
However, what most people
don’t know is thateven the most
advanced ones can’t block both!
Andyet, that’s exactly what
VeraFlexis designed to do and
why itworks sowell.
“Top pharma companies have
struggled to create a drug that
blocks COX and LOX; the medical
names for the two inflammatory
enzymes in the body. Consider
the top seller Celebrex, it only
blocks onevariation of the COX
enzyme”explains Leal.
“And that’s because they have
focused on using chemicals in-
stead of natural substances like
VeraFlex.”
“Every VeraFlex capsule
contains an ultra-high dose ofa
patented plantextract which has
been clinically shown to block
both enzymes, bringingrelief to
every joint that hurts!
“The kind of relief most
people have never experienced.
I often say two enzymes, twice
the relief. People think I’m kid-
ding until they try it.”
Piling on the Clinical
Research
Remarkably, the key ingredi-
ent inVeraFlexis protectedby